Establishment Labs Holdings Inc. (ESTA)

Market Cap	1.17B
Revenue (ttm)	166.03M
Net Income (ttm)	-84.60M
Shares Out	28.85M
EPS (ttm)	-3.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	247,374
Open	40.33
Previous Close	40.64
Day's Range	38.75 - 41.33
52-Week Range	28.16 - 60.12
Beta	0.95
Analysts	Buy
Price Target	59.17 (+46.35%)
Earnings Date	May 7, 2025

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells its products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 1,018
• Stock Exchange: NASDAQ
• Ticker Symbol: ESTA
• Website: https://www.establishmentlabs.com

Financial Performance

In 2024, ESTA's revenue was $166.03 million, an increase of 0.53% compared to the previous year's $165.15 million. Losses were -$84.60 million, 7.76% more than in 2023.

Analyst Forecast

According to 6 analysts, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $59.17, which is an increase of 46.35% from the latest price.

Price Target

$59.17

(46.35% upside)

Analyst Consensus: Buy